MELAS SyndromeSymptoms, Doctors, Treatments, Advances & More
MELAS Syndrome Overview
Learn About MELAS Syndrome
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is a condition that affects many of the body's systems, particularly the brain and nervous system (encephalo-) and muscles (myopathy). The signs and symptoms of this disorder most often appear in childhood following a period of normal development, although they can begin at any age. Early symptoms may include muscle weakness and pain, recurrent headaches, loss of appetite, vomiting, and seizures. Most affected individuals experience stroke-like episodes beginning before age 40. These episodes often involve temporary muscle weakness on one side of the body (hemiparesis), altered consciousness, vision abnormalities, seizures, and severe headaches resembling migraines. Repeated stroke-like episodes can progressively damage the brain, leading to vision loss, problems with movement, and a loss of intellectual function (dementia).
MELAS can result from mutations in one of several genes, including MT-ND1, MT-ND5, MT-TH, MT-TL1, and MT-TV. These genes are found in the DNA of cellular structures called mitochondria, which convert the energy from food into a form that cells can use. Although most DNA is packaged in chromosomes within the nucleus, mitochondria also have a small amount of their own DNA, known as mitochondrial DNA or mtDNA.
The exact incidence of MELAS is unknown. It is one of the more common conditions in a group known as mitochondrial diseases. Together, mitochondrial diseases occur in about 1 in 4,000 people.
This condition is inherited in a mitochondrial pattern, which is also known as maternal inheritance. This pattern of inheritance applies to genes contained in mtDNA. Because egg cells, but not sperm cells, contribute mitochondria to the developing embryo, children can only inherit disorders resulting from mtDNA mutations from their mother. These disorders can appear in every generation of a family and can affect both males and females, but fathers do not pass traits associated with changes in mtDNA to their children.
Ayman El-Hattab is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Columbia, Missouri. Dr. El-Hattab is rated as an Elite provider by MediFind in the treatment of MELAS Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses MELAS Syndrome, Neu Laxova Syndrome, Primary Carnitine Deficiency, and Microcephaly.
Baylor College Of Medicine
Fernando Scaglia is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Houston, Texas. Dr. Scaglia is rated as an Elite provider by MediFind in the treatment of MELAS Syndrome. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses MELAS Syndrome, Hypotonia, Primary Carnitine Deficiency, Leigh Syndrome, and Gastrostomy. Dr. Scaglia is currently accepting new patients.
Lisa Emrick is a Pediatrics specialist and a Pediatric Neurologist practicing medicine in Houston, Texas. Dr. Emrick is rated as an Elite provider by MediFind in the treatment of MELAS Syndrome. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses MELAS Syndrome, Hypotonia, CACH Syndrome, Cortical Dysplasia, and Gastrostomy. Dr. Emrick is currently accepting new patients.
Summary: Mitochondrial DNA (mtDNA) depletion syndromes (MDS) are a genetically and clinically heterogeneous group of autosomal recessive disorders that are characterized by a severe reduction in mtDNA content leading to impaired energy production in affected tissues and organs. MDS are due to defects in mtDNA maintenance caused by mutations in nuclear genes that function in either mitochondrial nucleotide ...
Summary: The KHENERFIN study aims to determine whether the study medicine, sonlicromanol, is able to reduce symptoms of fatigue and the impact of fatigue on daily life, and whether sonlicromanol is able to improve physical abilities of people like balance control and lower limb skeletal muscle strength in people with mitochondrial disease. In this study, the effects of sonlicromanol are compared against a ...
Published Date: December 01, 2013
Published By: National Institutes of Health